Linder N, Taushtein I, Handsher R, Ohel G, Reichman B, Barzilai A, Kuint J, Davidovitch N, Mendelson E, Dagan R
Department of Neonatology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Vaccine. 1998 Jan-Feb;16(2-3):236-9. doi: 10.1016/s0264-410x(97)00180-1.
This study was designed to investigate the placental transfer of maternal poliovirus antibodies in full-term and pre-term infants. Two hundred healthy, Israeli born mothers and their infants, were enrolled immediately after birth. The study population comprised two groups: a full-term group of 150 mothers and their infants, and a pre-term group of 50 mothers and their infants (gestational age < 35 weeks). Maternal and umbilical cord blood samples were taken in all cases. Antibody titers against the three poliovirus serotypes and a polio virus type 1 strain that caused an outbreak in 1988 (epidemic strain 1) were measured by a microneutralization system. The proportion of individuals with protective titers against each of the poliovirus types tested was slightly lower in the infants compared with their mothers. When protection to all strains combined was tested, the difference between mothers and infants was significant (P < 0.05). Transplacental transfer to epidemic strain 1 was less effective--12% of the premature infants were not protected against it at birth. The geometric mean titers against poliovirus types 1, 3 and epidemic type 1 strain were significantly lower in the pre-term group than in the full-term group. In both the full-term and pre-term groups there were significant linear correlations between the maternal and neonatal antibody titers for each of the polio viruses tested. For all poliovirus types, the transfer of maternal antibodies to the full-term infant was significantly higher than the transfer of maternal antibodies to the pre-term infant (P < 0.001). Owing to diminished transfer of maternal antibodies, pre-term infants are at greater risk of poliovirus infection.
本研究旨在调查足月和早产婴儿中母体脊髓灰质炎病毒抗体的胎盘转运情况。200名在以色列出生的健康母亲及其婴儿在出生后立即被纳入研究。研究人群包括两组:一组是150名母亲及其足月婴儿,另一组是50名母亲及其早产婴儿(胎龄<35周)。所有病例均采集了母体和脐带血样本。通过微量中和系统检测针对三种脊髓灰质炎病毒血清型以及1988年引起疫情爆发的1型脊髓灰质炎病毒株(流行株1)的抗体滴度。与母亲相比,婴儿中针对每种检测的脊髓灰质炎病毒类型具有保护性滴度的个体比例略低。当检测对所有毒株的综合保护时,母亲和婴儿之间的差异具有统计学意义(P<0.05)。胎盘向流行株1的转运效果较差——12%的早产儿出生时未受到该毒株的保护。早产组针对脊髓灰质炎病毒1型、3型和流行株1的几何平均滴度显著低于足月组。在足月组和早产组中,针对每种检测的脊髓灰质炎病毒,母体和新生儿抗体滴度之间均存在显著的线性相关性。对于所有脊髓灰质炎病毒类型,母体抗体向足月婴儿的转运显著高于向早产婴儿的转运(P<0.001)。由于母体抗体转运减少,早产婴儿感染脊髓灰质炎病毒的风险更高。